R&D Partnerships Exemplify IFPMA Assembly Theme “A Shared Commitment to Global Health” The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has just published the 2010 edition of its Status Report on Pharmaceutical Industry R&D for Diseases of the Developing World(1). The report highlights the increasing efforts of IFPMA member companies(2), working with partners or...
Read moreNew Vice Presidents are Mr. John Lechleiter of Lilly and Mr. Masafumi Nogimori of Astellas The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is pleased to announce that Mr. David Brennan, Chief Executive Officer of AstraZeneca has been elected IFPMA President. Mr. Brennan succeeds outgoing IFPMA President Mr. Haruo Naito, President and CEO of...
Read moreThe International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) held its 25 th Assembly today in Washington DC, USA. This biannual event brought together CEOs and senior figures from IFPMA member companies and associations. They were joined by senior figures from intergovernmental organizations, national governments, the Washington diplomatic community and health-related NGOs. IFPMA Director General,...
Read moreIFPMA Statement to the WIPO Standing Committee on the Law of Patents (SCP) Remarks by Mr. Andrew Jenner, Director, Intellectual Property & Trade, IFPMA Mr. Chairman The International Federation of Pharmaceutical Manufactures and Associations (IFPMA) would like to thank you for the opportunity to input on the important discussions within the SCP. The IFPMA represents...
Read moreThe research-based pharmaceutical industry represented by the IFPMA is providing emergency aid to assist Pakistan in coping with the health consequences of the extensive flooding it is experiencing. The total value of assistance provided so far by IFPMA member companies*, including both cash and donation of medicines and other medical supplies, amounts to USD 3.33...
Read moreThe United Nations Summit on the Millennium Development Goals on 20-22 September will review progress and look at ways of accelerating progress. The UN’s 2010 MDG Report indicates that the goals are achievable, despite uneven progress, and exhorts everyone to try to keep the promise of the Millennium Declaration. Mr. Haruo Naito, President of the...
Read more63rd WHO Regional Committee for South East Asia IFPMA Statement under agenda item 14, “Accelerating the achievement of MDG5: addressing inequity in maternal and neonatal health”. Delivered by Mr. Mario Ottiglio, Associate Director, Public Affairs & Global Health On behalf of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), I would like to thank...
Read moreA new IFPMA study 1 , announced today at the “Options for the Control of Influenza VII” conference in Hong Kong, shows that global vaccine coverage remains uneven and low overall, despite total distribution of seasonal influenza vaccines nearly doubling over the last six years. The study, which surveyed IFPMA influenza vaccine company members 2...
Read moreActions by R&D pharmaceutical companies that facilitate access to medicines Background/Rationale: IFPMA member companies are committed to improving access to antiretrovirals (ARVs) for those who cannot afford them, particularly in Least Developed Countries (LDCs) and low-income countries (LICs). For many years, the pharmaceutical industry has created and delivered ARVs that have saved millions of lives in the global...
Read moreThe International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the World Anti-Doping Agency (WADA) signed a Joint Declaration on Cooperation in the Fight against Doping in Sport today in Lausanne, Switzerland. The Declaration was signed by Mr. David Howman, Director General of WADA, and Mr. Haruo Naito, President of the IFPMA and President and...
Read moreImproving Responses to Future Influenza Pandemics Lessons from the 2009-10 H1N1 Pandemic The 2009-10 H1N1 influenza pandemic prompted the most robust and complete pandemic response ever. As with any major public health initiative of this scale, it is important that stakeholders undertake a careful analysis of the response. This will help enhance future preparedness, by building on those...
Read moreOn June 14, 2010, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) delivered a formal statement to the United Nations General Assembly Hearings with NGOs, Civil Society and the Private Sector on the UN Millennium Development Goals. The IFPMA, the only industry body selected to make such a statement, outlined its members’ major contributions...
Read more